Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 15, 2014 - Issue 11
Submit an article Journal homepage
718
Views
13
CrossRef citations to date
0
Altmetric
Drug Evaluations

Guanfacine extended release for the treatment of attention-deficit/hyperactivity disorder in children and adolescents

Daniel F ConnorUniversity of Connecticut School of Medicine and Health Care Center, Department of Psychiatry/MC1410, 263 Farmington Avenue, Farmington, 06030-1410 CT, USA+1 860 679 2730; +1 860 679 4326; [email protected]
, MD,
Amy FT ArnstenYale University School of Medicine, New Haven, CT, USA
, PhD,
Geraldine S PearsonUniversity of Connecticut School of Medicine and Health Care Center, Farmington, CT, USA
, PhD APRN PMH-CNS FAAN &
Gabriella F GrecoUniversity of Connecticut School of Medicine and Health Care Center, Farmington, CT, USA
, DO
Pages 1601-1610 | Published online: 03 Jul 2014

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Cliff Molife, Virginia S. Haynes, Allen Nyhuis, Douglas E. Faries, Steve Gelwicks, Douglas K. Kelsey & Carlos I. Alatorre. (2018) Healthcare utilization and costs of children with attention deficit/hyperactivity disorder initiating atomoxetine versus extended-release guanfacine. Current Medical Research and Opinion 34:4, pages 619-632.
Read now
James W Murrough, Sahab Yaqubi, Sehrish Sayed & Dennis S Charney. (2015) Emerging drugs for the treatment of anxiety. Expert Opinion on Emerging Drugs 20:3, pages 393-406.
Read now

Articles from other publishers (11)

Donald E. Greydanus, Dilip R. Patel & Dustin C. Rowland. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology 396 434 .
Donald E. Greydanus, Dustin C. Rowland, Dilip R. Patel & Neelkamal Soares. (2021) Psychopharmacology of Pediatric Attention-Deficit/Hyperactivity Disorder. Psychiatric Annals 51:10, pages 459-466.
Crossref
Wen-Yen Tseng, Ghazi Rekik, Chia-Hui Chen, Filipe M. Clemente, Pedro Bezerra, Zachary J. Crowley-McHattan & Yung-Sheng Chen. (2021) Effects of 8-Week FIFA 11+ for Kids Intervention on Physical Fitness and Attention in Elementary School Children. Journal of Physical Activity and Health 18:6, pages 686-693.
Crossref
Janet K. Johnson, Tesfaye Liranso, Keith Saylor, Gabriela Tulloch, Toyin Adewole, Stefan Schwabe, Azmi Nasser, Robert L. Findling & Jeffrey H. Newcorn. (2019) A Phase II Double-Blind, Placebo-Controlled, Efficacy and Safety Study of SPN-812 (Extended-Release Viloxazine) in Children With ADHD. Journal of Attention Disorders 24:2, pages 348-358.
Crossref
Deepan SinghYuji WakimotoCarole FilangieriAaron PinkhasovMoris Angulo. (2019) Guanfacine Extended Release for the Reduction of Aggression, Attention-Deficit/Hyperactivity Disorder Symptoms, and Self-Injurious Behavior in Prader-Willi Syndrome—A Retrospective Cohort Study. Journal of Child and Adolescent Psychopharmacology 29:4, pages 313-317.
Crossref
Stephen V. Faraone, Anthony L. Rostain, Joseph Blader, Betsy Busch, Ann C. Childress, Daniel F. Connor & Jeffrey H. Newcorn. (2019) Practitioner Review: Emotional dysregulation in attention-deficit/hyperactivity disorder - implications for clinical recognition and intervention. Journal of Child Psychology and Psychiatry 60:2, pages 133-150.
Crossref
Arie Kaffman, Jordon D. White, Lan Wei, Frances K. Johnson & John H. Krystal. 2019. Psychiatric Disorders. Psychiatric Disorders 3 22 .
Stacy M. Ku & Ming-Hu Han. (2017) HCN Channel Targets for Novel Antidepressant Treatment. Neurotherapeutics 14:3, pages 698-715.
Crossref
S. A. Hassani, M. Oemisch, M. Balcarras, S. Westendorff, S. Ardid, M. A. van der Meer, P. Tiesinga & T. Womelsdorf. (2017) A computational psychiatry approach identifies how alpha-2A noradrenergic agonist Guanfacine affects feature-based reinforcement learning in the macaque. Scientific Reports 7:1.
Crossref
Mark J. Millan, Guy M. Goodwin, Andreas Meyer-Lindenberg & Sven Ove Ögren. (2015) Learning from the past and looking to the future: Emerging perspectives for improving the treatment of psychiatric disorders. European Neuropsychopharmacology 25:5, pages 599-656.
Crossref
Chao-Lin Ma, Xuan Sun, Fei Luo & Bao-Ming Li. (2015) Prefrontal cortical α2A-adrenoceptors and a possible primate model of attention deficit and hyperactivity disorder. Neuroscience Bulletin 31:2, pages 227-234.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.